• 28 OctCoherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development

• 28 OctLatham Group, Inc. to Participate at Conferences in November and December 2026

• 28 OctAdamas Trust, Inc. Reports Third Quarter 2026 Results, Maintains Focus on Disciplined Portfolio Management

• 28 OctYYForce Targets 100% Malaysia Revenue Growth to US$20 Million in FY2027

• 28 OctChurchill Downs Incorporated Announces New $750 Million Share Repurchase Program

• 28 OctChurchill Downs Incorporated Appoints Michael Tucker to Board of Directors

• 28 OctMIMEDX Announces Third Quarter 2026 Operating & Financial Results

• 28 OctAdial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

• 28 OctNewtekOne, Inc. Reports 3Q26 Basic and Diluted EPS of $0.34

• 28 OctChurchill Downs Incorporated Receives Local Approvals for New HRM Entertainment Venue in Henry County, Virginia

• 28 OctARS Pharma to Report Third Quarter 2026 Financial Results

• 28 OctSPACCircle Acquisition Corp. Completes $100 Million Initial Public Offering

• 28 OctMIMEDX Announces $25 Million Patent License Agreement

• 28 OctKymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026

• 28 OctLiberty Global to Present at the Morgan Stanley European Technology, Media & Telecom Conference

• 28 OctThoroughbred Championship Series Expands to Include Oaks Division for Three-Year-Old Fillies